A

NantHealth investor filed suit in federal court this week against Dr. Patrick Soon-Shiong and his health technology company, alleging violations of federal securities laws. The lawsuit follows the publication of a STAT investigation that showed how the biotech billionaire used a philanthropic donation to steer business back to his company.

The suit was filed on behalf of a single investor; the complaint indicated that the legal team may ask a judge to expand it to a class action if additional investors come forward.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Let’s see, Rebecca is reporting that a single investor has filed lawsuit against NH based on her STAT article? Would any real newspaper report this? Never. Shareholder lawsuits are filed all the time and never amount to anything. Why would any newspaper report on a single investor filing a shareholder lawsuit against a company? Would she write an article if I filed a meaningless lawsuit against her? These are the tactics of a pure smear campaign, not journalism.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy